Skip to content

Duckweed Intake Study

Tolerance of Regular Intake of Duckweed Based Food Products

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03677583
Acronym
DIS
Enrollment
24
Registered
2018-09-19
Start date
2018-10-01
Completion date
2018-10-15
Last updated
2018-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Complication

Brief summary

The study aims to study the impact of frequent intake of 150-180 gram duckweed on gastrointestinal complaints and several other health related biomarkers. The study has a randomised parallel design. Two different treatments will be evaluated e.g. a 11-day intervention with duckweed based meals and a 11-day intervention with control/spinach meals. At the start and at the end of the intervention we will collect a blood sample and a urine samples. Questionnaires about gut complaints, stool consistency and frequency, wellbeing, health complaints or other adverse effects will be collected daily during intervention and up to two days after the intervention.

Detailed description

The study aims to study the impact of frequent intake of 150-180 gram duckweed on gastrointestinal complaints and several other health related biomarkers. Objective: The primary objective is to investigate gastro-intestinal complaints during 11 day duckweed consumption. Secondary objectives are to assess blood based parameters related to general health and urine based biomarkers for kidney function and to investigate consumer acceptance. Study design: The study has a randomised parallel design. Two different treatments will be evaluated e.g. a 11-day intervention with duckweed based meals and a 11-day intervention with control/spinach meals. At the start and at the end of the intervention we will collect a blood sample and a urine samples. Questionnaires about gut complaints, stool consistency and frequency, wellbeing, health complaints or other adverse effects will be collected daily during intervention and up to two days after the intervention. Study population: We aim to include 24 healthy volunteers aged 18-50 years. Intervention: A 11-day intervention in which subjects will receive a daily lunch with 150-180g wet weight duck weed or spinach. Products will be incorporated in food products such as pasta, curry, soup etc. Main study parameters/endpoints: The main study parameter is frequency and severity of gastro-intestinal complaints. Secondary outcomes are intestinal health parameters derived from blood and urine samples taken before and after the intervention.

Interventions

various meal products such as meal soup, quiche, mashed potato, curry and pasta sauce

OTHERSpinach

various meal products such as meal soup, quiche, mashed potato, curry and pasta sauce

Sponsors

Wageningen University and Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Apparently healthy men and women * Age between 18 and 50 years * Body mass index (BMI) between 18.5 and 24.9 kg/m2

Exclusion criteria

* Any metabolic, gastrointestinal, inflammatory or chronic disease (such as diabetes, anaemia, hepatitis, cardiovascular disease) * History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints * History of liver dysfunction (cirrhosis, hepatitis) or liver surgery * Kidney dysfunction (self-reported) * Use of medication that may influence the study results, such as gastric acid inhibitors or laxatives * Reported slimming, medically prescribed or vegan/vegetarian diet * Current smokers * Alcohol intake ≥4 glasses of alcoholic beverages per day * Pregnant, lactating or wishing to become pregnant in the period of the study (self-reported) * Abuse of illicit drugs * Food allergies for products that we use in the study * Participation in another clinical trial at the same time * Being an employee of the department Consumer Science & Health group of Wageningen Food & Biobased Research

Design outcomes

Primary

MeasureTime frameDescription
change in gastro-intestinal complaintsDaily, during 11 days of duckweed intake and up to three days after intake. By questionnaires and Visual Analogue Scale (VAS) scores; from no complains (minimal) to serious complains (maximum)). Higher values represent a worse outcomebloated feeling, belching, abdominal pain, flatulence, nausea, diarrhoea, constipation measured via Visual Analogue Scale (VAS)

Secondary

MeasureTime frameDescription
change in blood hemoglobinbefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in blood glucosebefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in blood Fe (Iron)before (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in blood leukocyte cell countsbefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in blood ALATbefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in blood GGTbefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in blood creatininebefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in blood CRPbefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in blood zonulinbefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions
change in urinary biomarkers of healthbefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeoxalic acid
change in blood pressurebefore (D=0) and after (D=11) 11 days of duckweed or spinach intakesystolic and diastolic bloodpressure
change in blood eGFRbefore (D=0) and after (D=11) 11 days of duckweed or spinach intakeunder fasting conditions

Other

MeasureTime frameDescription
fiber, fruit and vegetable intakebefore the intervention (D=0), this questionaire provides insights in energy and macronutrient consumptionvia a food frequency questionaire

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026